Clinical Perspectives

Novel Immunotherapy Trial using Chimeric Antigen Receptor Therapy (CAR T) for Relapsed Epithelial Ovarian Cancer

Dr. Robert M. Wenham, chair of Moffitt’s Department of Gynecologic Oncology, is leading the CAR T clinical trial designed to treat women with...

Understanding the Effects of the COVID Vaccine on Cancer Patients

To help better understand the effects of the COVID vaccine on cancer patients, Moffitt Cancer Center launched a study following patients before and...

A new type of CAR T called UltraCAR-T™ potentially a therapy for myeloid malignancies

A phase 1b study that was presented at the 2021 American Society of Hematology annual meeting looks at the safety and efficacy of a new type of CAR T...

Predicting Outcomes to Immunotherapy for NSCLC

There is an urgent need to identify biomarkers that can predict which patients will not respond to therapy and administer potential beneficial drugs...

Therapeutic Treatment Advancement for Metastatic HER2-positive Breast Cancer

The treatment paradigm of HER2-positive breast cancer has grown significantly for early-stage and metastatic settings. Dr. Christine Sam discusses...

Moffitt and Ringling College of Art Design Partner Utilizing Virtual Reality to Enhance the Patient Experience

Moffitt and Ringling are excited about the opportunities this technology could provide for cancer patients and the talented RCAD VR students. With...

New Tools and Techniques for Improved Surgical Outcomes for Patients with Brain Tumors

The goals of brain tumor surgery are to obtain tissue for diagnosis/classification and remove as much of the bulk tumor as possible. One of the key...

The Utility of Trastuzumab Monotherapy in HER2+ Breast Cancer

Older cancer patients who are reluctant to receive chemotherapy could be effectively treated with trastuzumab monotherapy without significantly...

Endometrial Cancer: Routes of Surgery

"Minimally invasive surgery should be embraced as the standard surgical approach for comprehensive staging in women with endometrial cancer," says...

Virtual Cancer Care Enhances Our Patient Experience

The virulent spread of COVID-19 throughout the country over a year and a half ago has resulted in an urgent mandate for the utilization of...

New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients

Moffitt is one of a few hospitals nationwide testing ALLO-501a, an allogeneic CAR T therapy product from Allogene Therapeutics, in combination with...

Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver

Moffitt Cancer Center is leading the research in rare sarcomas and has performed the most comprehensive molecular analysis to-date of...

GRECO-2 Trial Could Show Promising Results for Pancreatic Cancer

Moffitt was one of the high-volume centers with the last trial, which showed improved outcomes. Moffitt researchers are hopeful that this current...

Percutaneous Hepatic Perfusion in Patients with Hepatic-dominant Ocular Melanoma

The analysis indicated that PHP demonstrated a statistically superior overall response rate and significantly prolonged progression-free survival in...

TVEC for the Treatment of Early Stage Triple Negative Breast Cancer

TVEC is designed to preferentially lyse tumor cells over normal tissue to release tumor associated antigens, produces GM-CSF to activate dendritic...